Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in ...

China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...

Ultragenyx Pharmaceutical and Mereo BioPharma Group saw their shares plummet after ringing out 2025 by announcing the failures of their brittle bone disease candidate setrusumab (UX143) in a pair of ...

UCLA Health experts say long-term threats to lung health, mental well-being and overall community wellness remain, long after ...

GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.

In recent years, virtual care and wearable health devices have opened new possibilities by giving clinicians clearer ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

We currently know that COPD, and specifically emphysema, don’t just happen alongside lung cancer; they increase a person’s ...

Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...

Patients who have comorbid COPD with heart failure and ischemic heart disease have increased health care resource use and higher mortality.

Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need ...